EP2268310
USE OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY (ADCC) IN COMBINATION WITH CYCLOPHOSPHAMIDE, VINCRISTINE AND DOXORUBICINE FOR TREATING NON-HODGKIN' S LYMPHOMAS
:
EP einkaleyfi: Þýðing ekki lögð inn:
23.3.2009:
20.7.2016:
09723808.3
:
22.3.2029
:
USE OF A TYPE II ANTI-CD20 ANTIBODY WITH INCREASED ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY (ADCC) IN COMBINATION WITH CYCLOPHOSPHAMIDE, VINCRISTINE AND DOXORUBICINE FOR TREATING NON-HODGKIN' S LYMPHOMAS
23.3.2009
20.7.2016
:
Roche Glycart AG:
Wagistrasse 18, 8952, Schlieren-Zuerich, CH
:
DUMONTET, Charles:
Venissieux, FR
:
FRIESS, Thomas:
Diessen-Dettenhofen, DE
:
HERTING, Frank:
Penzberg, DE
:
KLEIN, Christian:
Bonstetten, CH
:
UMANA, Pablo:
Wollerau, CH
:
08005554:
25.3.2008:
EP
:
08007172:
11.4.2008:
EP
:
EP2009002111:
23.3.2009
:
A61K 39/395, C07K 16/28, A61P 35/00